An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets. (2021)
Attributed to:
Using whole genome sequencing to characterise drug resistant Mycobacterium tuberculosis in Thailand
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13073-020-00822-6
PubMed Identifier: 33413610
Publication URI: http://europepmc.org/abstract/MED/33413610
Type: Journal Article/Review
Volume: 13
Parent Publication: Genome medicine
Issue: 1
ISSN: 1756-994X